Is there a personalized medicine for mood disorders?
暂无分享,去创建一个
[1] P. McGuffin,et al. The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update , 2010, Molecular Psychiatry.
[2] R. Duman,et al. Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications , 2008, Biological Psychiatry.
[3] D. DeMets,et al. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.
[4] Tomas Novak,et al. The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments , 2010, European Neuropsychopharmacology.
[5] A. Meyer-Lindenberg,et al. Intermediate or brainless phenotypes for psychiatric research? , 2009, Psychological Medicine.
[6] M. Danhof,et al. The missing link between clinical endpoints and drug targets in depression. , 2010, Trends in pharmacological sciences.
[7] A. Ehlis,et al. Consensus paper of the WFSBP Task Force on Biological Markers: Biological Markers in Depression , 2007, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[8] P. Popik,et al. Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. , 2010, Journal of affective disorders.
[9] K. Lesch,et al. Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.
[10] I. Gottesman,et al. The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.
[11] J. Groves,et al. Is it time to reassess the BDNF hypothesis of depression? , 2007, Molecular Psychiatry.
[12] G. Hankey,et al. Homocysteine and depression in later life. , 2008, Archives of general psychiatry.
[13] A. Meyer-Lindenberg,et al. Intermediate phenotypes and genetic mechanisms of psychiatric disorders , 2006, Nature Reviews Neuroscience.
[14] Christian Scharinger,et al. Imaging genetics: implications for research on variable antidepressant drug response , 2010, Expert review of clinical pharmacology.
[15] Andreas Meyer-Lindenberg,et al. Imaging genetics: Progressing by leaps and bounds , 2010, NeuroImage.
[16] H. Kraemer,et al. Untreated depression and hippocampal volume loss. , 2003, The American journal of psychiatry.
[17] A. Caspi,et al. Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.
[18] Kevin S. LaBar,et al. Mood Alters Amygdala Activation to Sad Distractors During an Attentional Task , 2006, Biological Psychiatry.
[19] M. Wong,et al. Research and treatment approaches to depression , 2001, Nature Reviews Neuroscience.
[20] Joan Y. Chiao,et al. Culture–gene coevolution of individualism–collectivism and the serotonin transporter gene , 2009, Proceedings of the Royal Society B: Biological Sciences.
[21] W. Drevets,et al. Imaging phenotypes of major depressive disorder: genetic correlates , 2009, Neuroscience.
[22] D. Segal. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) , 2010 .
[23] A. Serretti,et al. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder , 2010, Molecular Psychiatry.
[24] A. Meyer-Lindenberg,et al. Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression , 2008, Molecular Psychiatry.
[25] J. Salonen,et al. Association between depressive symptoms and serum concentrations of homocysteine in men: a population study. , 2004, The American journal of clinical nutrition.
[26] N. Risch,et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. , 2009, JAMA.
[27] A. Rush,et al. Folate and unipolar depression. , 2008, Journal of alternative and complementary medicine.
[28] F. Holsboer. How can we realize the promise of personalized antidepressant medicines? , 2008, Nature Reviews Neuroscience.
[29] F. Zitman,et al. Stimulated Gene Expression Profiles as a Blood Marker of Major Depressive Disorder , 2010, Biological Psychiatry.
[30] Z. Bhagwagar,et al. Antidepressant Response and the Serotonin Transporter Gene-Linked Polymorphic Region , 2010, Biological Psychiatry.
[31] A. Coppen,et al. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. , 2000, Journal of affective disorders.
[32] L. Parsons,et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. , 1999, The American journal of psychiatry.
[33] Joshua R. Smith,et al. Serotonin transport kinetics correlated between human platelets and brain synaptosomes , 2005, Psychopharmacology.
[34] Harald H. Sitte,et al. Imaging genetics of mood disorders , 2010, NeuroImage.